An open-label randomized, multicenter study in patients with asthma to evaluate the effectiveness of Alvesco (ciclesonide) compared to asthma usual care in a primary practice setting.
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms ACCEPT
- Sponsors ALTANA Pharma; Takeda Pharmaceuticals International GmbH
- 07 May 2012 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 30 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.